Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Net Income (2016 - 2025)

Medifast (MED) has disclosed Net Income for 16 consecutive years, with -$18.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Income fell 2376.26% year-over-year to -$18.1 million, compared with a TTM value of -$18.7 million through Dec 2025, down 985.35%, and an annual FY2025 reading of -$18.7 million, down 994.68% over the prior year.
  • Net Income was -$18.1 million for Q4 2025 at Medifast, down from -$2.3 million in the prior quarter.
  • Across five years, Net Income topped out at $47.0 million in Q2 2021 and bottomed at -$18.1 million in Q4 2025.
  • Average Net Income over 5 years is $19.5 million, with a median of $24.8 million recorded in 2022.
  • Peak annual rise in Net Income hit 130.37% in 2025, while the deepest fall reached 2376.26% in 2025.
  • Year by year, Net Income stood at $34.0 million in 2021, then dropped by 22.06% to $26.5 million in 2022, then tumbled by 77.24% to $6.0 million in 2023, then crashed by 86.81% to $796000.0 in 2024, then crashed by 2376.26% to -$18.1 million in 2025.
  • Business Quant data shows Net Income for MED at -$18.1 million in Q4 2025, -$2.3 million in Q3 2025, and $2.5 million in Q2 2025.